Microtech Medical

What Microtech Medical does

Microtech Medical (微泰医疗) is a Hangzhou-based medical device company founded in 2011 that designs, manufactures, and commercializes hardware for diabetes management. Its portfolio spans three integrated pillars: continuous glucose monitoring (AiDEX CGM, LinX CGM sensors), insulin delivery (Equil tubeless patch insulin pump), and blood glucose monitoring (Exactive BGM family, POCT HbA1c/CRP analyzer), with a developer-facing AiDEX API and a Pancares data management platform. LinX has obtained both China NMPA approval and the CE mark, and an upcoming Closed Loop Artificial Pancreas product targets automated insulin delivery. The company is publicly listed on the Hong Kong Stock Exchange (SEHK:2235).

The company's revenue model is built on hardware sales of devices plus recurring consumables (CGM sensors, infusion sets, test strips). Distribution is multi-channel: direct website sales, regional e-commerce storefronts (Amazon Spain/Italy, Shopee, Lazada, AliExpress), and a growing network of international distributors — notably Tranz Pharma Holdings for Sri Lanka, with product training and exhibition presence in Europe and the Americas (MEDICA, WHX Miami). Customers span Type 1 and Type 2 diabetes patients, healthcare providers, and — increasingly — athletes and health-conscious consumers using CGM for metabolic optimization.

Microtech Medical has raised approximately $173M cumulatively across six funding rounds (2016-2020) from IDG Capital, Qiming Venture Partners, Lilly Asia Ventures, CICC Jiacheng, and others, before its public listing. The company employs 501-1,000 people and operates from its headquarters in Hangzhou Future Sci-Tech City. Leadership is anchored by founder Pan Zheng (Chairman & CEO) and co-founder Dore Mark (Technology). Reported financials show a roughly 4x multi-year revenue trajectory with EBITDA inflecting to positive in 2025, alongside active patent filing in US and European patent offices for CGM and wearable glucose monitoring technology.

Name

Microtech Medical

Legal name

MicroTech Medical (Hangzhou) Co., Ltd.

Website

https://microtechmd.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Microtech Medical is a Hangzhou-based, publicly listed medical device company that develops and sells CGM sensors, a tubeless patch insulin pump, and blood glucose meters for diabetes patients, healthcare providers, and prosumers across Asia, Europe, and the Americas.

Ownership category

akta.pro rank

Product category

Diabetes Management Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Continuous Glucose Monitoring (CGM) Systems (HLAHAHAA)

akta.pro secondary industries

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG), Diabetes Care Device Accessories & Adhesives (Sensors/Pump Supplies) (HLAHAHAL), Insulin Pen Needles, Syringes & Infusion Sets (Consumables) (HLAHAHAE), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Continuous glucose monitoring
• Insulin pump systems
• Diabetes management devices
• Blood glucose monitoring
• Point-of-care testing

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. CGM Systems and Sensors: Sale of continuous glucose monitoring systems and disposable sensors. Products include AiDEX CGM System and LinX CGM System Sensor. Revenue is generated from both initial device sales and recurring sensor purchases.
2. Insulin Pump Systems: Sale of Equil Patch Insulin Pump systems and associated consumables (infusion sets, reservoirs). The tubeless design provides differentiation in the insulin pump market.
3. Blood Glucose Monitoring Systems: Sale of blood glucose meters and test strips. Multiple product lines including Exactive Pro, Exactive Easy, Exactive EQ Simple, Exactive EQ Impulse, Exactive Vital, Insight Connect, and GoChek2 Connect.
4. POCT Analyzer Systems: Point-of-care testing devices for HbA1c, CRP, and microalbumin testing, targeting healthcare providers and clinics.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Microtech Medical develops, manufactures, and sells integrated diabetes management medical devices. Its core product portfolio includes continuous glucose monitoring (CGM) systems (AiDEX and LinX sensors), a tubeless patch insulin pump (Equil), a family of blood glucose meters (Exactive line), and a point-of-care testing (POCT) analyzer for HbA1c, CRP, and microalbumin. Revenue is generated through hardware sales of devices and recurring consumables (sensors, infusion sets, test strips), distributed via direct e-commerce, international distributors, and clinical channels across Asia, Europe, and the Americas.

Product overview

Microtech Medical offers an integrated diabetes management portfolio centered on three core pillars: continuous glucose monitoring (CGM), insulin delivery, and blood glucose monitoring. The main products are: (1) Equil™ Patch Insulin Pump - a tubeless patch pump for continuous insulin delivery; (2) AiDEX™ CGM System and LinX CGM System Sensor - wearable devices providing real-time glucose monitoring with 15-day sensor life; (3) A family of Exactive™ blood glucose meters including EQ Simple, Easy, EQ Impulse, Vital, Pro (multi-analyte: glucose/ketone/uric acid), and connected models (Insight Connect, GoChek2 Connect with Bluetooth); (4) POCT Analyzer System for point-of-care testing of HbA1c, CRP, and MAU; (5) Closed Loop Artificial Pancreas - an upcoming automated insulin delivery system; and (6) AiDEX API for developer access to CGM data. The portfolio is designed to address the full spectrum of diabetes management from monitoring to therapy delivery.

Differentiator

Problem solved

Functional benefit

Brands

• Equil: Equil Patch Insulin Pump System - tubeless insulin pump for continuous insulin delivery
• AiDEX
• LinX
• Exactive
• Pancares
• AiDEX API

Quantifiable outcome

• 15-day sensor life (LinX CGM)
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature4 records

Partnerships

Two partnerships are on record, tiered regional and minor.

• Tranz Pharma HoldingsregionalChannel Partner/ Reseller/ Distributor · 2 November 2025Tranz Pharma Holdings in Sri Lanka launched the Continuous Glucose Monitoring System (CGMS) called 'AIDEX X', produced by Microtech Medical in China. This partnership extends Microtech's distribution reach into the South Asian market through a local pharmaceutical distribution partner.
• Andon HealthminorOthersBoth Micro Tech Medical (Hangzhou) and Andon Health are identified as Chinese assignees actively expanding into Western IP jurisdictions, filing patents in US and European patent offices for wearable glucose monitoring technology.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Dexcom: Global CGM leader with G6/G7 systems. Compares directly to Microtech's AiDEX and LinX CGM lines on the same core product category targeting diabetes patients with real-time glucose monitoring.
• Abbott Diabetes Care: Maker of FreeStyle Libre family of CGMs, the global CGM volume leader. Directly comparable to Microtech's factory-calibrated LinX CGM in disposable sensor form factor and 14-15 day wear time.
• Medtronic Diabetes: Vertically integrated diabetes care company offering CGM (Guardian), insulin pumps (MiniMed), and closed-loop systems (780G). Closest comparable to Microtech's integrated CGM + Equil pump + nascent closed-loop strategy.
• Insulet Corporation: Maker of Omnipod tubeless patch insulin pump, the most direct competitor to Microtech's Equil Patch Insulin Pump in the tubeless CSII segment.
• Tandem Diabetes Care: Specialist insulin pump company with t:slim X2 and Control-IQ automated insulin delivery. Comparable to Microtech's insulin pump and emerging closed-loop artificial pancreas roadmap.
• Ypsomed: European-based diabetes care company with mylife Loop insulin pump and CGM partnerships. Comparable to Microtech's pump business and European footprint via CE Mark.
• Sinocare Inc. Chinese-listed diabetes care company focused on BGM meters and test strips, with growing CGM presence. Closest comparable domestic Chinese peer across the same BGM and diabetes devices categories.

Emerging players

• Andon Health: Chinese medical device manufacturer with CGM and connected BGM products. Comparable to Microtech as a fellow Chinese challenger expanding into Western IP markets and overlapping BGM/CGM lines.
• Senseonics Holdings: Developer of the Eversense implantable long-term CGM system. Comparable to Microtech as a CGM-focused player pursuing differentiated long-wear sensor technology against Dexcom/Abbott incumbents.

Broad incumbents

• Roche Diabetes Care: Major diabetes care incumbent with Accu-Chek BGM and insulin pump systems. Comparable to Microtech's BGM meter portfolio (Exactive, GoChek, Insight Connect) and broader diabetes franchise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/MicroTechDiabet
• YouTubeyoutube.com/channel/UCj0kkbtIviIj4WbOvjM_wfQ
• Facebookfacebook.com/MicroTechMedicalDiabetes
• LinkedInlinkedin.com/company/microtechmedical
• Instagraminstagram.com/microtech_medical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds6 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Microtech Medical